BV100 is a novel intravenous formulation of rifabutin based on the newly identified mode of action for the active uptake of rifabutin into the Acinetobacter baumannii-calcoaceticus complex. BV100 is ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

The study found that about 7% of ICU patients carried C. auris during their stay, with over a third acquiring it inside the ICU, suggesting most transmission occurs within hospitals.

The changing natural and social environments, coupled with pathogen mutations, have led to a spike in the emergence of new infectious diseases. This presents a severe medical challenge for the world.

Mycobacteria are a group of microorganisms with defined characteristics, widely distributed in various environments, including water and soil. They can be classified into mycobacteria causing ...

Scientists have designed nanoagents that act like smart drug-delivery capsules—carrying an antibiotic deep into bacterial ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Understand the significance of proteo-transcriptomics in identifying vulnerabilities in Candida auris and addressing drug resistance.

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If ...

DENVER -- The two-drug combination of doravirine and islatravir was as efficacious as the three-drug regimen of bictegravir, ...